NCT02989870 Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE1
NCT02988440 Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients Status COMPLETED Phase PHASE1
NCT02987907 The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial. Status UNKNOWN Phase PHASE3
NCT02987699 Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil Status UNKNOWN Phase PHASE2
NCT02981498 Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02973685 HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. Status COMPLETED Phase PHASE3
NCT02973516 Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis Status COMPLETED Phase PHASE2
NCT02971345 Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus Status UNKNOWN Phase PHASE3
NCT02968810 Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02961998 Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail Status COMPLETED Phase PHASE4
NCT02960620 Therasphere for Unresectable Primary or Secondary Liver Neoplasia Status NO_LONGER_AVAILABLE Phase N/A
NCT02960594 hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Status COMPLETED Phase PHASE1
NCT02959359 DAA in the Risk of Recurrence After Curative Treatment of HCC Status WITHDRAWN Phase PHASE4
NCT02950025 Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies Status TERMINATED Phase PHASE2
NCT02946138 Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2
NCT02942329 Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02936856 Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications Status UNKNOWN Phase NA
NCT02935478 Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation Status SUSPENDED Phase NA
NCT02928627 Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma Status TERMINATED Phase N/A